The metabolic syndrome defined by modified International Diabetes Federation criteria and mortality: A 9-year follow-up of the aged in Finland;Syndrome métabolique (défini par les critères révisés de l'IDF) et mortalité suivi durant neuf ans de sujets âgés finlandais.

Diabetes and Metabolism

Volumn 36, Issue 6, 2010, Pages 437-442

  Salminen, M ^a,b,c   Kuoppamaki M ^a,d   Vahlberg, T ^a   Raiha I ^a,e   Irjala, K ^f   Kivela S L ^a,c,g  

^a UNIVERSITY OF TURKU   (Finland)

^b Harkatie Health Centre   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d Naantali Health Centre   (Finland)

^e TURKU CITY HOSPITAL   (Finland)

^f Mehilainen Corporation   (Finland)

^g SATAKUNTA CENTRAL HOSPITAL   (Finland)

Author keywords

Aged; Elderly; Finland; Metabolic syndrome; Mortality; Population based study

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT; FEMALE; FINLAND; HUMAN; HYPERTENSION; INTERNATIONAL DIABETES FEDERATION CRITERIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; OBESITY; PREDICTIVE VALIDITY; PROSPECTIVE STUDY; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CORONARY DISEASE; FEMALE; FINLAND; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MORTALITY; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SOCIETIES, MEDICAL;

EID: 78649999047     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2010.05.002     Document Type: Article

References (40)

1. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365:1415-1428.
2. Park H.S., Song Y.M., Cho S.I. Obesity has greater impact on cardiovascular mortality in younger men than in older men among non-smoking Koreans. Int J Epidemiol 2006, 35:181-187.
3. Abell J.E., Egan B.M., Wilson P.W., Lipsitz S., Woolson R.F., Lackland D.T. Age and race impact the association between BMI and CVD mortality in women. Public Health Rep 2007, 122:507-512.
4. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
5. Mozaffarian D., Kamineni A., Prineas R.J., Siscovick D.S. Metabolic syndrome and mortality in older adults. The Cardiovascular Health Study. Arch Intern Med 2008, 168:969-978.
6. Mackenbach J.P., Kunst A.E., Lautenbach H., Oei Y.B., Bijlsma F. Gains in life expectancy after elimination of major causes of death: revised estimates taking into account the effect of competing causes. J Epidemiol Community Health 1999, 53:32-37.
7. Wang J., Ruotsalainen S., Moilanen L., Lepistö P., Laakso M., Kuusisto J. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 2007, 28:857-864.
8. Morley J.E., Sinclair A. The metabolic syndrome in older persons: a loosely defined constellation of symptoms or a district entity?. Age Ageing 2009, 38:494-497.
9. Isoaho R., Puolijoki H., Huhti E., Kivelä S.L., Laippala P., Tala E. Prevalence of chronic obstructive pulmonary disease in elderly Finns. Respir Med 1994, 88:571-580.
10. Löppönen M., Räihä I., Isoaho R., Vahlberg T., Kivelä S.L. Diagnosing cognitive impairment and dementia in primary health care-a more active approach is needed. Age Ageing 2003, 32:606-612.
11. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation, Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999.
12. Alberti K., Zimmet P., Shaw F. The metabolic syndrome - a new worldwide definition. Lancet 2005, 366:1059-1062. for the IDF Epidemiology Task Force Consensus Group.
13. Zimmet P., Magliano D., Matsuzawa Y., Alberti G., Shaw J. The metabolic syndrome: a global health problem and a new definition. J Atheroscler Thromb 2005, 12:295-300.
14. Hildrum B, Mykletun A, Dahl AA, Midthjell. Metabolic syndrome and risk of mortality in middle-aged versus elderly individuals: the Nord-Trondelag Health Study (HUNT). Diabetologia 2009;52:583-90.
15. Zambon S., Zanoni S., Romanato G., Chiara Corti M., Noale M., Sartori L., et al. Metabolic syndrome and all-cause and cardiovascular mortality in an Italian elderly population. Diabetes Care 2009, 32:153-159.
16. Näyhä S. Geographical variations in cardiovascular mortality in Finland, 1961-1985. Scand J Soc Med 1989, 40:S1-S48.
17. Salomaa V., Arstila M., Kaarsalo, Ketonen M., Kuulasmaa K., Lehto S., et al. Trends in the incidence of and mortality from coronary heart disease in Finland, 1983-1988. Am J Epidemiol 1992, 136:1303-1315.
18. Pajunen P., Torppa J., Huohvanainen M., Salomaa V., Vartiainen E. Sepelvaltimotautikuolleisuuden itä-länsiero kaventunut miehillä 30 vuoden seuranta-aikana. [The difference in coronary heart disease mortality among men from eastern and western Finland has decreased over the past 30 years]. Suom Lääkäril [J Finnish Med Assoc] 2004, 59:5013-5016. [English Abstract].
19. Tong P.C., Kong A.P., So W.Y., Yang X., Ho C.S., Ma R.C., et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Porgram's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 2007, 30:1206-1211.
20. Saely C.H., Koch L., Schmid F., Marte T., Aczel S., Langer P., et al. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 2006, 29:901-907.
21. The DECODE Study Group. Does the constellation of risk factors with and without abdominal adiposity associate with different cardiovascular mortality risk? Int J Obes 2008; 32:757-62.
22. Gallagher D., Visser M., Sepúlveda D., Pierson R.N., Harris T., Heymsfield S.B. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?. Am J Epidemiol 1996, 143:228-239.
23. Jackson A.S., Stanforth P.R., Gagnon J., Rankinen T., Leon A.S., Rao D.C., et al. The effects of sex, age, and race on estimating percentage body fat from body mass index: The Heritage Family Study. Int J Obes 2002, 26:789-796.
24. Barlett H.L., Puhl S.M., Hodgson J.L., Buskirk E.R. Fat-free mass in relation to stature: rations of fat-free mass on height in children, adults, and elderly subjects. Am J Clin Nutr 1991, 53:1112-1116.
25. Baumgartner R.N., Heymsfield S.B., Roche A.F. Human body composition and the epidemiology of chronic disease. Obes Res 1995, 3:73-95.
26. Kahn R., Buse J., Ferrannini E., Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005, 28:2289-2304.
27. Sundström J., Risérus U., Byberg L., Zethelius B., Lithell H., Lind L. Clinical value of the metabolic syndrome for long-term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ 2006, 332:878-882.
28. Huang K.-C., Lee L.T., Chen C.Y., Sung P.K. All-cause and cardiovascular disease mortality increased with metabolic syndrome in Taiwanese. Obesity 2008, 16:684-689.
29. Cooney M.T., Dudina A., De Bacquer D., Wilhelmsen L., Sans S., Menotti A., et al. HDL cholesterol protects against cardiovascular disease in both genders at all ages and at all level of risk. Atherosclerosis 2009, 206:611-616.
30. Castelli W.P., Garrison R.J., Wilson P.W., Abbott R.D., Kalousdian S., Kannel W.B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986, 256:2835-2838.
31. Mazza A., Tikhonoff V., Schiavon L., Casiglia E. Triglycerides+high-density-lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: the cardiovascular study in the elderly. Int Med J 2005, 35:604-610.
32. Assman G., Schulte R. Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Munster Study. Am J Cardiol 1992, 8:99-103.
33. Castelli W.P. Epidemiology of triglyserides: a view from Framingham. Am J Cardiol 1992, 70:3H-9H.
34. LaRosa J.C. Triglyserides and coronary risk in women and the elderly. Arch Intern Med 1997, 157:961-968.
35. Bushy W.J., Campbell A.J., Robertson M.C. Is low blood pressure in elderly people just a consequence of heart disease and frailty?. Age Ageing 1994, 23:69-74.
36. Hakala S.-M., Tilvis R.S. Determinants and significance of declining blood pressure in old age. Eur Heart J 1998, 19:1872-1878.
37. Boshuizen H.C., Izaks G.J., van Buuren S., Ligthart G.J. Blood pressure and mortality in elderly people aged 85 and older: community based study. BMJ 1998, 316:1780-1784.
38. Rastas S., Pirttilä T., Viramo P., Verkkoniemi A., Halonen P., Juva K., et al. Association between blood pressure and survival over 9 years in a general population aged 85 and older. J Am Geriatr Soc 2006, 54:912-918.
39. Okumiya K., Matsubayashi K., Wada T., Fujisawa M., Osaki Y., Doi Y., et al. A U-shaped association between home systolic blood pressure and four-year mortality in community-dwelling older men. J Am Geriatr Soc 1999, 47:1415-1421.
40. Vischer U.M., Safar M.E., Laria P., Le Dudal K., Henry O., Herrmann F.R., et al. Cardiometabolic determinants of mortality in a geriatric population: is there a "reverse metabolic syndrome" ?. Diabetes Metab 2009, 35:108-114.